Cargando...
Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma
Adjuvant chemotherapy for osteosarcoma and Ewing sarcoma consists of conventional cytotoxic regimens that have changed little over the past decades. There is an urgent need for agents that are more effective and have less long-term toxicity. Receptor tyrosine kinases regulate cell growth and prolife...
Guardado en:
| Publicado en: | Pediatr Blood Cancer |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8238849/ https://ncbi.nlm.nih.gov/pubmed/33894051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.29084 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|